NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Global Brokerage JPMorgan Upgrades Hindalco Industries and Vedanta

Shares of Hindalco Industries and Vedanta rose significantly in Tuesday's trade, with both companies experiencing gains of up to 3 percent. The increase in stock prices can be attributed to global brokerage JPMorgan upgrading both stocks, citing expectations of sustained higher aluminium prices and improved profitability.

JPMorgan's Upgrades and Price Targets

JPMorgan has raised its rating on Hindalco Industries and Vedanta to "overweight" from "neutral", indicating a shift in the brokerage's confidence in the companies' prospects. Furthermore, JPMorgan has increased the price targets for both companies, implying potential upside of up to 22 percent.

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

CompanyPrevious RatingNew RatingPrevious Price TargetNew Price TargetPotential Upside
Hindalco IndustriesNeutralOverweightRs 875Rs 1,12520%
VedantaNeutralOverweightRs 680Rs 85022%

Hindalco Industries' Performance

Shares of Hindalco Industries climbed over 4 percent to Rs 964.9 per share on the NSE, marking the fifth straight session of gains. The stock has risen nearly 10 percent during this period. The brokerage has increased Hindalco's price target to Rs 1,125 per share from Rs 875, indicating a potential upside of about 20 percent from its previous close. JPMorgan attributes the improved profitability to the restart of the Oswego plant and gains from higher scrap spreads at Hindalco's subsidiary Novelis.

Vedanta Shares Advance

Read also: MarketSmith India's 4 June Stock Recommendations

Vedanta shares also advanced over 4 percent to Rs 718.95 per share on the NSE. JPMorgan has raised Vedanta's price target to Rs 850 per share from Rs 680, indicating a potential upside of about 22 percent from its previous closing level. The brokerage notes that Vedanta's risk-reward has turned favourable, with its estimated enterprise value to EBITDA for FY2027 at around 4 times. It adds that strength in aluminium and zinc businesses is expected to offset weakness in oil and gas volumes.

Market Outlook

JPMorgan's report highlights the potential for sustained higher aluminium prices due to geopolitical tensions in West Asia. The brokerage expects earnings growth to be driven by higher prices on the London Metal Exchange and rupee depreciation. Additionally, JPMorgan notes that recent supply disruptions due to smelter outages in the region could further contribute to elevated aluminium prices. The brokerage believes that tailwinds from the commodity cycle could help ease recent debt concerns for both companies, while the recent correction in stock prices has made valuations more attractive.

Investor Takeaway

Investors should consider upgrading their rating on Hindalco Industries and Vedanta due to JPMorgan's bullish outlook.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.